1 | patients | 644,976 |
2 | cirrhotics | 49 |
3 | paraplegics | 25 |
4 | patiens | 12 |
5 | icu-patients | 9 |
6 | gazelles | 8 |
7 | puerperae | 8 |
8 | implantees | 7 |
9 | ewe-lambs | 6 |
10 | lumberjacks | 6 |
11 | pateints | 6 |
12 | -patients | 5 |
13 | cad-patients | 5 |
14 | llsccs | 5 |
15 | case-patients | 4 |
16 | neurotics | 4 |
17 | ostomates | 4 |
18 | pa-tients | 4 |
19 | bmcss | 3 |
20 | heteropolymers | 3 |
21 | jills | 3 |
22 | manics | 3 |
23 | non-abstainers | 3 |
24 | parients | 3 |
25 | patierts | 3 |
26 | zonkizizwe | 3 |
27 | 0'b | 2 |
28 | 2.1-2.26 | 2 |
29 | ami-survivors | 2 |
30 | copds | 2 |
31 | cyclooctynes | 2 |
32 | flavonoides | 2 |
33 | glenoids | 2 |
34 | ivrb | 2 |
35 | kcal/unit | 2 |
36 | nsclc-patients | 2 |
37 | predistention | 2 |
38 | stz-rats | 2 |
39 | .neonates | 1 |
40 | 6-nitroquinoxaline-2,3-diones | 1 |
41 | 61couples | 1 |
42 | amino-acid-long | 1 |
43 | angiosomes | 1 |
44 | check-points | 1 |
45 | endo-cycloadducts | 1 |
46 | et-patients | 1 |
47 | guatemalans | 1 |
48 | heteroarylimino-1,3-thiazolidinones | 1 |
49 | hiv+patients | 1 |
50 | kcal/m2/h | 1 |
51 | k∕min | 1 |
52 | mg/day+dcm | 1 |
53 | mhz/t | 1 |
54 | mono-oder | 1 |
55 | mr-examinations | 1 |
56 | non-tcbz | 1 |
57 | paients | 1 |
58 | participants.compared | 1 |
59 | patientas | 1 |
60 | patients-12 | 1 |
61 | patinets | 1 |
62 | physically-well | 1 |
63 | prostatectomy-patients | 1 |
64 | stroke-relevant | 1 |
65 | sub-arrays | 1 |
66 | subgroups.patients | 1 |
67 | ua-patients | 1 |
68 | vai-courses | 1 |
69 | well-disciplined-those | 1 |
70 | years.treatment | 1 |
71 | ≤16-year-olds | 1 |
1 | -patients | 5 |
2 | .neonates | 1 |
3 | 0'b | 2 |
4 | 2.1-2.26 | 2 |
5 | 6-nitroquinoxaline-2,3-diones | 1 |
6 | 61couples | 1 |
7 | ami-survivors | 2 |
8 | amino-acid-long | 1 |
9 | angiosomes | 1 |
10 | bmcss | 3 |
11 | cad-patients | 5 |
12 | case-patients | 4 |
13 | check-points | 1 |
14 | cirrhotics | 49 |
15 | copds | 2 |
16 | cyclooctynes | 2 |
17 | endo-cycloadducts | 1 |
18 | et-patients | 1 |
19 | ewe-lambs | 6 |
20 | flavonoides | 2 |
21 | gazelles | 8 |
22 | glenoids | 2 |
23 | guatemalans | 1 |
24 | heteroarylimino-1,3-thiazolidinones | 1 |
25 | heteropolymers | 3 |
26 | hiv+patients | 1 |
27 | icu-patients | 9 |
28 | implantees | 7 |
29 | ivrb | 2 |
30 | jills | 3 |
31 | kcal/m2/h | 1 |
32 | kcal/unit | 2 |
33 | k∕min | 1 |
34 | llsccs | 5 |
35 | lumberjacks | 6 |
36 | manics | 3 |
37 | mg/day+dcm | 1 |
38 | mhz/t | 1 |
39 | mono-oder | 1 |
40 | mr-examinations | 1 |
41 | neurotics | 4 |
42 | non-abstainers | 3 |
43 | non-tcbz | 1 |
44 | nsclc-patients | 2 |
45 | ostomates | 4 |
46 | pa-tients | 4 |
47 | paients | 1 |
48 | paraplegics | 25 |
49 | parients | 3 |
50 | participants.compared | 1 |
51 | pateints | 6 |
52 | patiens | 12 |
53 | patientas | 1 |
54 | patients | 644,976 |
55 | patients-12 | 1 |
56 | patierts | 3 |
57 | patinets | 1 |
58 | physically-well | 1 |
59 | predistention | 2 |
60 | prostatectomy-patients | 1 |
61 | puerperae | 8 |
62 | stroke-relevant | 1 |
63 | stz-rats | 2 |
64 | sub-arrays | 1 |
65 | subgroups.patients | 1 |
66 | ua-patients | 1 |
67 | vai-courses | 1 |
68 | well-disciplined-those | 1 |
69 | years.treatment | 1 |
70 | zonkizizwe | 3 |
71 | ≤16-year-olds | 1 |
1 | patients-12 | 1 |
2 | 2.1-2.26 | 2 |
3 | 0'b | 2 |
4 | ivrb | 2 |
5 | participants.compared | 1 |
6 | puerperae | 8 |
7 | well-disciplined-those | 1 |
8 | zonkizizwe | 3 |
9 | amino-acid-long | 1 |
10 | kcal/m2/h | 1 |
11 | physically-well | 1 |
12 | mg/day+dcm | 1 |
13 | k∕min | 1 |
14 | predistention | 2 |
15 | mono-oder | 1 |
16 | patientas | 1 |
17 | ewe-lambs | 6 |
18 | llsccs | 5 |
19 | paraplegics | 25 |
20 | manics | 3 |
21 | cirrhotics | 49 |
22 | neurotics | 4 |
23 | glenoids | 2 |
24 | ≤16-year-olds | 1 |
25 | copds | 2 |
26 | flavonoides | 2 |
27 | implantees | 7 |
28 | gazelles | 8 |
29 | 61couples | 1 |
30 | angiosomes | 1 |
31 | 6-nitroquinoxaline-2,3-diones | 1 |
32 | heteroarylimino-1,3-thiazolidinones | 1 |
33 | cyclooctynes | 2 |
34 | vai-courses | 1 |
35 | ostomates | 4 |
36 | .neonates | 1 |
37 | lumberjacks | 6 |
38 | jills | 3 |
39 | guatemalans | 1 |
40 | patiens | 12 |
41 | mr-examinations | 1 |
42 | heteropolymers | 3 |
43 | non-abstainers | 3 |
44 | ami-survivors | 2 |
45 | bmcss | 3 |
46 | stz-rats | 2 |
47 | endo-cycloadducts | 1 |
48 | patinets | 1 |
49 | paients | 1 |
50 | parients | 3 |
51 | pa-tients | 4 |
52 | patients | 644,976 |
53 | hiv+patients | 1 |
54 | -patients | 5 |
55 | ua-patients | 1 |
56 | nsclc-patients | 2 |
57 | cad-patients | 5 |
58 | case-patients | 4 |
59 | et-patients | 1 |
60 | icu-patients | 9 |
61 | prostatectomy-patients | 1 |
62 | subgroups.patients | 1 |
63 | pateints | 6 |
64 | check-points | 1 |
65 | patierts | 3 |
66 | sub-arrays | 1 |
67 | mhz/t | 1 |
68 | kcal/unit | 2 |
69 | stroke-relevant | 1 |
70 | years.treatment | 1 |
71 | non-tcbz | 1 |